cycloheximide has been researched along with sulindac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Jang, D; Manfield, L; Murrell, GA | 1 |
| Adam, L; Kumar, R; Mandal, M | 1 |
3 other study(ies) available for cycloheximide and sulindac
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Nitric oxide enhances cyclooxygenase activity in articular cartilage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Cattle; Cells, Cultured; Child; Cycloheximide; Cyclooxygenase Inhibitors; Dinoprostone; Escherichia coli; Female; Humans; Interleukin-1; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Protein Synthesis Inhibitors; Sulindac; Tumor Necrosis Factor-alpha | 1996 |
Redistribution of activated caspase-3 to the nucleus during butyric acid-induced apoptosis.
Topics: Apoptosis; Butyric Acid; Caspase 3; Caspase Inhibitors; Caspases; Catalytic Domain; Cell Nucleus; Colorectal Neoplasms; Cycloheximide; Cysteine Proteinase Inhibitors; Cytosol; DNA-Activated Protein Kinase; DNA-Binding Proteins; Enzyme Activation; Enzyme Precursors; Humans; Microscopy, Confocal; Molecular Weight; Nuclear Proteins; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Sulindac; Tumor Cells, Cultured | 1999 |